EGFR and lung carcinoma: In addition, our data are consistent with recent reports46, 47, 48 showing that ZEB1 or NOTCH1 promotes EMT and EGFR inhibitor resistance in lung cancer cell lines, including HCC4006, PC9 and H1650.